PLSH
PANACEA LIFE SCIENCES HOLDINGS, INC.
-0.01 (-7.91%)0.09USD93.0K成交股數1.5M市值–本益比(近四季)0.5股價營收比+55.9%營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 24Q1 | 23Q4 | 23Q3 | 23Q2 | 23Q1 | 22Q3 | 22Q2 | 22Q1 | 21Q4 | 21Q3 | 21Q2 | 21Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 1.1M+56% | 960K+162% | 348K-26% | 399K-14% | 677K+5% | 366K-38% | 469K+50% | 466K-9% | 646K | 588K | 313K | 512K |
| 營業成本 | 390K | 414K | 201K | 196K | 452K | 319K | 332K | 366K | 636K | 305K | 249K | 330K |
| 毛利 | 666K+195% | 547K+1056% | 147K+6% | 203K+102% | 226K+2067% | 47K-83% | 138K+113% | 100K-45% | 10K | 283K | 65K | 182K |
| 毛利率 | 63.1% | 56.9% | 42.1% | 50.8% | 33.3% | 12.9% | 29.4% | 21.5% | 1.6% | 48.1% | 20.7% | 35.6% |
| 研發費用 | – | – | – | – | – | – | – | – | – | – | – | – |
| 銷售管理費用 | 249K | 777K | 277K | 145K | 257K | 262K | 205K | 461K | 607K | 291K | 335K | 286K |
| 營業利益 | −1.1M-18% | −1.8M+27% | −1.4M+14% | −1.1M-35% | −1.3M-40% | −1.4M+10% | −1.2M-14% | −1.6M+51% | −2.1M | −1.3M | −1.4M | −1.1M |
| 營業利益率 | -100.1% | -184.1% | -406.5% | -269.1% | -190.4% | -379.2% | -264.1% | -353.3% | -332.5% | -213.9% | -459.1% | -213.2% |
| 稅後淨利 | −1.4M-19% | −2.2M-18% | −2.2M+10% | −1.9M-33% | −1.8M-14% | −2.7M-13% | −2.0M-7309% | −2.8M-851% | −2.1M | −3.1M | 27K | 371K |
| 淨利率 | -136.9% | -230.0% | -618.4% | -467.1% | -264.4% | -735.5% | -417.9% | -596.4% | -323.6% | -525.4% | 8.7% | 72.4% |
| 稀釋 EPS | -0.09-25% | -0.12-33% | -0.130% | -0.11-42% | -0.12-20% | -0.18+29% | -0.13 | -0.19-1050% | -0.15 | -0.14 | 0.00 | 0.02 |
| 稀釋股數 | 16.5M | 16.6M | 16.6M | 17.6M | 15.0M | 14.9M | 15.0M | 14.8M | 17.8M | 21.4M | 16.9M | 21.9M |
資產負債表 期末餘額
| 科目 | 24Q1 | 23Q4 | 23Q3 | 23Q2 | 23Q1 | 22Q3 | 22Q2 | 22Q1 | 21Q4 | 21Q3 | 21Q2 | 21Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 108K | 101K | 1K | 8K | 73K | 37K | 37K | 56K | 20K | 15K | 131K | 20K |
| 應收帳款 | 271K | 264K | 309K | 272K | 275K | 222K | 220K | 163K | 244K | 515K | 290K | – |
| 存貨 | 4.1M | 4.0M | 4.7M | 4.4M | 4.1M | 4.4M | 4.5M | 4.3M | 4.3M | 4.3M | 4.3M | 11K |
| 總資產 | 17.4M | 18.0M | 18.7M | 17.9M | 18.6M | 20.0M | 22.0M | 22.4M | 23.8M | 24.2M | 26.8M | 58K |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 27.0M | 26.3M | 24.8M | 23.4M | 22.4M | 20.4M | 19.7M | 18.2M | 16.7M | 15.8M | 15.3M | 3.6M |
| 股東權益 | −9.6M | −8.3M | −6.1M | −5.6M | −3.8M | −440K | 2.3M | 4.2M | 7.1M | 8.4M | 11.5M | 7.1M |
| 負債比 | 155.3% | 146.1% | 132.5% | 131.2% | 120.5% | 102.2% | 89.7% | 81.3% | 70.1% | 65.3% | 57.1% | 6,230.6% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 24Q1 | 23Q4 | 23Q3 | 23Q2 | 23Q1 | 22Q3 | 22Q2 | 22Q1 | 21Q4 | 21Q3 | 21Q2 | 21Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | −357K+14% | – | – | – | −314K | – | – | −436K-45% | – | – | – | −795K |
| 資本支出 | 5K | – | – | – | 15K | – | – | 10K | – | – | – | 87K |
| 自由現金流 | −362K+10% | – | – | – | −329K | – | – | −446K-49% | – | – | – | −882K |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | -34.3% | – | – | – | -48.6% | – | – | -95.6% | – | – | – | -172.2% |
營收拆解 2022 年度 10-K 的分部揭露 · 年增對前一年度
地區2022 年度 · 2.9M
| Largo Florida | 2.9M | 100.0% | – |
|---|
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2023 | 2.4M | +46.6% | −8.0M | -336.1% | -0.48 | −1.6M |
| FY2022 | 1.6M | -21.0% | −9.1M | -561.9% | -0.62 | −2.6M |
| FY2021 | 2.1M | -77.2% | −4.8M | -232.2% | -0.27 | −4.1M |
| FY2020 | 9.0M | +2508.7% | −5.2M | -58.0% | -0.31 | −10.8M |
| FY2019 | 346K | – | −10.0M | -2,898.3% | -0.30 | −6.3M |
| FY2018 | 0 | – | −4.3M | –% | -0.91 | −466K |